OraSure Technologies, Inc. (NASDAQ: OSUR), a diagnostic and oral fluid specimen collection device company, has reported a cybersecurity incident that resulted in unauthorized access to company data. The breach was first detected on or about March 27, 2024, and the company has since taken steps to address the situation.
The company initiated its response protocols immediately upon discovering the breach, which included launching an investigation with the help of cybersecurity experts and external legal counsel, as well as informing law enforcement authorities. OraSure has stated that it believes the incident has been contained and that the integrity of its core financial and operational systems remains intact.
While the investigation determined that certain files were removed from the company's systems, OraSure is still in the process of assessing the full scope of sensitive information that may have been compromised, including any personal data. The company is also evaluating the necessity for regulatory and legal notifications and will proceed with such notifications as required.
As of now, OraSure has not observed a material impact on its operations or financial systems due to the breach. The company's information systems are currently functional and it does not foresee any significant future impact on its financial health or operational results. However, the investigation is ongoing as OraSure works to ascertain the complete ramifications of the incident.
This news is based on a recent statement from an SEC filing by OraSure Technologies. The company is continuing to monitor the situation closely and will provide updates as more information becomes available.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.